SINGAPORE, May 15 (Reuters) – IHH Healthcare has signed a S$250 million ($196 million) sustainability-linked loan with Singapore’s biggest bank DBS that ties part of the deal to better use of antibiotics at its four Singapore hospitals, the companies said on Friday.
• The loan sets targets for Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals to improve checks on whether patients still need antibiotics within 72 hours of starting treatment.
• IHH and DBS said the goal is to cut misuse of antibiotics, which can help drug-resistant bacteria spread and make infections harder to treat.
• IHH said the plan supports Singapore’s national effort to fight antimicrobial resistance.
($1 = 1.2772 Singapore dollars)
(Reporting by Yantoultra NguiEditing by Shri Navaratnam)
